Three different treatment strategies are currently under investigation to determine how to optimally improve upon tamoxifen: an aromatase inhibitor as a replacement for 5 years of tamoxifen (early ...

which is significant as aromatase inhibitor users were older than women receiving tamoxifen by an average of approximately 9 years. Reportedly, the authors secondarily controlled for age and still ...

the aromatase inhibitor letrozole markedly improves disease-free survival (DFS) compared with tamoxifen. Now, the BIG 1-98 investigators report that letrozole is superior to tamoxifen for the ...